Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126155782 | 12615578 | 2 | F | 201607 | 20160805 | 20160802 | 20160808 | PER | US-009507513-1607USA003303 | MERCK | 56.53 | YR | F | Y | 0.00000 | 20160808 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126155782 | 12615578 | 1 | PS | INTRON A | INTERFERON ALFA-2B | 1 | Subcutaneous | 18 MILLION IU, 3 TIMES PER WEEK | U | M002230 | 103132 | 18 | MIU | POWDER FOR INJECTION | |||||
126155782 | 12615578 | 2 | C | ATENOLOL. | ATENOLOL | 1 | 0 | TABLET | |||||||||||
126155782 | 12615578 | 3 | C | HYDROCHLOROT | HYDROCHLOROTHIAZIDE | 1 | UNK | 0 | TABLET | ||||||||||
126155782 | 12615578 | 4 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
126155782 | 12615578 | 5 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
126155782 | 12615578 | 6 | C | ESTRADIOL. | ESTRADIOL | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126155782 | 12615578 | Alopecia | |
126155782 | 12615578 | Influenza like illness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126155782 | 12615578 | 1 | 2016 | 0 |